Canadian Natural Resources Shares Higher After Dividend Lifted
By Robb M. Stewart
Canadian Natural Resources' shares advanced Thursday after the energy company boosted its dividend after achieving record quarterly production volumes.
In morning trading, the shares were 1.3% higher at C$90.90 in Toronto, widening the advance so far this year to 21%. On the New York Stock Exchange, the stock was ahead 1.9% at $65.89, for a year-to-date gain of 19%.
Canadian Natural Resources' board has approved an 11% increase to the base dividend to C$1 a share, which the company said demonstrated confidence in the sustainability of the business model, a strong balance sheet and the reserves and asset base. With the increase, the dividend has been raised 18% this year to C$4 a share annually.
The company posted net earnings of 2.34 billion Canadian dollars ($1.69 billion), or C$2.13 a share, up strongly from the quarter before but down from C$2.81 billion, or C$2.49, a year earlier.
On an adjusted basis, per-share earnings came in at C$2.59, beating the C$2.43 mean estimate of 11 analysts polled by FactSet.
The company's daily production for the quarter averaged 1.39 million oil-equivalent barrels, the highest in the company's history, up from 1.19 million the previous quarter and 1.34 million barrels a year earlier as output of natural gas and crude oil and natural gas liquids increased.
With its financial results, the energy company said President Tim McKay plans to retire next summer. In the interim, he will take on the role of vice chairman, while Scott Stauth, a veteran of 26 years with the company and currently chief operating office for the oil sands business, will be promoted to president.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
November 02, 2023 10:13 ET (14:13 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth